{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:41:09Z","timestamp":1791848469365,"version":"4.3.4"},"reference-count":35,"publisher":"Microbiology Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"abstract":"<jats:p>Decades after smallpox was eradicated and vaccination discontinued, the level of residual immunity in today's population is largely unknown. This study describes an epidemiological assessment in Italians of antibodies against the intracellular mature virus (IMV) and extracellular envelope virus (EEV) forms of <jats:italic>Vaccinia virus<\/jats:italic>. Serum samples (<jats:italic>n<\/jats:italic>=642) were taken in 1993 and 2003 from people between 11 and 102\u2005years old. Most citizens &gt;27\u2005years old were positive for antibodies to IMV and EEV. These antibodies were long-lasting and similar titres were present in citizens between 30 and 100\u2005years old. Serum samples from 1993 and 2003 displayed very similar EEV- and IMV-specific antibody titres. By using these data and demographic considerations, it was predicted that, in 2003, 46\u200a% of the Italian population were positive for both IMV and EEV, 42\u200a% were negative for both and 12\u200a% were positive for one antigen.<\/jats:p>","DOI":"10.1099\/vir.0.81265-0","type":"journal-article","created":{"date-parts":[[2005,10,14]],"date-time":"2005-10-14T04:12:50Z","timestamp":1129263170000},"page":"2955-2960","source":"Crossref","is-referenced-by-count":67,"title":["Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy"],"prefix":"10.1099","volume":"86","author":[{"given":"Mike M.","family":"P\u00fctz","sequence":"first","affiliation":[{"name":"Department of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, London W2 1PG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Alberini","sequence":"additional","affiliation":[{"name":"Department of Physiopathology, Experimental Medicine and Public Health, University of Siena, Via A. Moro, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Midgley","sequence":"additional","affiliation":[{"name":"Department of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, London W2 1PG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Manini","sequence":"additional","affiliation":[{"name":"Department of Physiopathology, Experimental Medicine and Public Health, University of Siena, Via A. Moro, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Montomoli","sequence":"additional","affiliation":[{"name":"Department of Physiopathology, Experimental Medicine and Public Health, University of Siena, Via A. Moro, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey L.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, London W2 1PG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1128\/JVI.79.10.6260-6271.2005","article-title":"Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R","volume":"79","author":"Aldaz-Carroll","year":"2005","journal-title":"J Virol"},{"key":"R2","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1128\/JVI.78.8.3811-3816.2004","article-title":"Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells","volume":"78","author":"Amara","year":"2004","journal-title":"J Virol"},{"key":"R3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1099\/0022-1317-13-1-9","article-title":"An antigenic difference between intracellular and extracellular rabbitpox virus","volume":"13","author":"Appleyard","year":"1971","journal-title":"J Gen Virol"},{"key":"R4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"key":"R5","first-page":"86","article-title":"Differences between extracellular and intracellular forms of poxvirus and their implications","volume":"16","author":"Boulter","year":"1973","journal-title":"Prog Med Virol"},{"key":"R6","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20032083","article-title":"Distinct time effects of vaccination on long-term proliferative and IFN- \u03b3 -producing T cell memory to smallpox in humans","volume":"199","author":"Combadiere","year":"2004","journal-title":"J Exp Med"},{"key":"R7","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J Immunol"},{"key":"R8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1073\/pnas.0408782102","article-title":"Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery","volume":"102","author":"Davies","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/aje\/kwg225","article-title":"Analysis of historical data suggests long-lasting protective effects of smallpox vaccination","volume":"158","author":"Eichner","year":"2003a","journal-title":"Am J Epidemiol"},{"key":"R10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/aje\/kwg104","article-title":"Case isolation and contact tracing can prevent the spread of smallpox","volume":"158","author":"Eichner","year":"2003b","journal-title":"Am J Epidemiol"},{"key":"R11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/infdis\/161.3.446","article-title":"The persistence of neutralizing antibodies after revaccination against smallpox","volume":"161","author":"el-Ad","year":"1990","journal-title":"J Infect Dis"},{"key":"R12","volume-title":"Smallpox and its Eradication","author":"Fenner","year":"1988"},{"key":"R13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature02007","article-title":"Planning for smallpox outbreaks","volume":"425","author":"Ferguson","year":"2003","journal-title":"Nature"},{"key":"R14","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J Virol"},{"key":"R15","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1001\/jama.289.24.3295","article-title":"Response to smallpox vaccine in persons immunized in the distant past","volume":"289","author":"Frey","year":"2003","journal-title":"JAMA"},{"key":"R16","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1128\/JCM.41.9.4068-4070.2003","article-title":"Smallpox: residual antibody after vaccination","volume":"41","author":"Gallwitz","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"key":"R18","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/414748a","article-title":"Transmission potential of smallpox in contemporary populations","volume":"414","author":"Gani","year":"2001","journal-title":"Nature"},{"key":"R19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(05)70234-8","article-title":"Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial","volume":"365","author":"Greenberg","year":"2005","journal-title":"Lancet"},{"key":"R20","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med"},{"key":"R21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/rmv.361","article-title":"Studies in smallpox and vaccination","volume":"12","author":"Hanna","year":"2002","journal-title":"Rev Med Virol"},{"key":"R22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/CDLI.12.4.520-524.2005","article-title":"Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations","volume":"12","author":"Hatakeyama","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"R23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"key":"R24","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1086\/423848","article-title":"Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination","volume":"190","author":"Kennedy","year":"2004","journal-title":"J Infect Dis"},{"key":"R25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.2000.0750","article-title":"Antibody neutralization of the extracellular enveloped form of vaccinia virus","volume":"280","author":"Law","year":"2001","journal-title":"Virology"},{"key":"R26","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1099\/vir.0.80660-0","article-title":"An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model","volume":"86","author":"Law","year":"2005","journal-title":"J Gen Virol"},{"key":"R27","first-page":"466","article-title":"The antibody response in man following infection with viruses of the pox group","volume":"56","author":"McCarthy","year":"1958","journal-title":"II. Antibody response following vaccination. J Hyg (Lond"},{"key":"R28","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.vaccine.2004.02.034","article-title":"Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB\/c mice from a lethal intranasal poxvirus challenge","volume":"22","author":"Pulford","year":"2004","journal-title":"Vaccine"},{"key":"R29","volume-title":"Report of the Investigation into the Cause of the 1978 Birmingham Smallpox Occurrence","author":"Shooter","year":"1980"},{"key":"R30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri845","article-title":"Smallpox: anything to declare?","volume":"2","author":"Smith","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R31","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J Gen Virol"},{"key":"R32","first-page":"22","article-title":"In Il vaiolo e la vaccinazione in Italia","volume":"vol. I","author":"Tagarelli","year":"2004"},{"key":"R33","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1099\/0022-1317-78-8-2041","article-title":"Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation","volume":"78","author":"Vanderplasschen","year":"1997","journal-title":"J Gen Virol"},{"key":"R34","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1073\/pnas.95.13.7544","article-title":"Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope","volume":"95","author":"Vanderplasschen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.micinf.2005.02.004","article-title":"Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees","volume":"7","author":"Viner","year":"2005","journal-title":"Microbes Infect"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.81265-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T10:30:42Z","timestamp":1603362642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.81265-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,1]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1099\/vir.0.81265-0","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,1]]}}}